EmployblEmploybl logo
employbl
ESCAPE Bio logo

ESCAPE Bio Funding & Investors

Escape Bio, Inc. operates as a preclinical stage biopharmaceutical company. The Company discovers and develops small molecule drugs and medicines to treat genetically-defined subpopulations in neurodegenerative diseases. Escape Bio serves customers in the State of California.

escapebio.com

Total Amount Raised: $187,076,080

ESCAPE Bio Funding Rounds

  • Series Unknown

    $73,000,000

    Series Unknown Investors

    Johnson & Johnson Innovation – JJDC
    Sutter Hill Ventures
    Novo Holdings
    Avidity Partners
    New Leaf Ventures
    Sphera Funds Management
    Surveyor Capital
    Novartis Venture Fund
    Wellington Management
    Osage University Partners
    OrbiMed Advisors
    Rock Springs Capital
    CAM Capital

  • Series Unknown

    $31,073,380

  • Series A

    $63,000,000

    Series A Investors

    Novartis Venture Fund
    Sutter Hill Ventures
    Novo Holdings
    Osage University Partners
    OrbiMed Advisors
    Johnson & Johnson Innovation

  • Series Unknown

    $20,002,700

Funding info provided by Diffbot.